Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service
Background The incidence of high-grade immune-related adverse events (irAEs) due to immune checkpoint inhibitors (ICIs) is increasing due to the rapid expansion of indications for their use. There is an urgent need for a feasible approach of identifying patients with high-grade irAEs to ensure early...
Saved in:
| Main Authors: | Michael Manos, Patrick Ott, Osama Rahma, F Stephen Hodi, Shilpa Grover, Peter Bowling, Jian Ni, Nicole R LeBoeuf, Osama Abu-Shawer, Prabhsimranjot Singh, Eric Yenulevich, Amanda Brito, Raja-Elie E Abdulnour, Joseph Jacobson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-10-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/8/2/e000992.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy
by: Laura C Cappelli, et al.
Published: (2024-04-01) -
Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)
by: A Daban, et al.
Published: (2023-12-01) -
Antiviral therapy can effectively suppress irAEs in HBV positive hepatocellular carcinoma treated with ICIs: validation based on multi machine learning
by: Shuxian Pan, et al.
Published: (2025-01-01) -
YUNUS EMRE BİBLİYOGRAFYASI
by: Mustafa CAN
Published: (2016-01-01) -
Effects of Dietary Nano-Composite of Copper and Carbon on Antioxidant Capacity, Immunity, and Cecal Microbiota of Weaned Ira White Rabbits
by: Ying-Huan Zhou, et al.
Published: (2025-01-01)